Biogen Inc.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spina…
Drug Manufacturers - General
US, Cambridge [HQ]
BIIB/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,377.00 | 4,716.00 | 5,048.00 | 5,516.00 | 6,932.00 | 9,703.00 | 10,763.00 | 11,448.00 | 12,273.00 | 13,452.00 | 14,377.00 | 13,444.00 | 10,981.00 | 10,173.00 | 9,835.00 | |
|
EPS
|
3.37 | 3.98 | 5.09 | 5.80 | 7.86 | 12.42 | 15.38 | 16.96 | 11.94 | 21.62 | 31.47 | 24.86 | 10.44 | 20.97 | 8.02 | |
| Diluted in mil. | 3.35 | 3.94 | 5.04 | 5.76 | 7.81 | 12.37 | 15.34 | 16.93 | 11.92 | 21.58 | 31.42 | 24.80 | 10.40 | 20.87 | 7.97 | |
|
Profit
|
3,995.00 | 4,316.00 | 4,581.00 | 4,970.00 | 6,074.00 | 8,532.00 | 9,523.00 | 9,970.00 | 10,643.00 | 11,636.00 | 12,422.00 | 11,639.00 | 8,872.00 | 7,895.00 | 7,302.00 | |
| Gross Margin | 91.27 | 91.51 | 90.75 | 90.11 | 87.63 | 87.93 | 88.48 | 87.08 | 86.72 | 86.50 | 86.40 | 86.57 | 80.79 | 77.61 | 74.24 | |
| Pre Tax | 1,332.00 | 1,229.00 | 1,711.00 | 1,855.00 | 2,480.00 | 3,946.00 | 4,767.00 | 4,933.00 | 5,128.00 | 5,899.00 | 7,125.00 | 5,047.00 | 1,745.00 | 3,591.00 | 1,296.00 | |
| Profit Margin | 30.44 | 26.08 | 33.89 | 33.63 | 35.78 | 40.67 | 44.29 | 43.09 | 41.79 | 43.85 | 49.56 | 37.54 | 15.89 | 35.31 | 13.18 | |
| ETR | 26.68 | 26.94 | 25.98 | 25.37 | 24.23 | 25.08 | 24.37 | 25.08 | 47.94 | 24.16 | 16.25 | 19.66 | 3.01 | 17.62 | 10.43 | |
| Net | 970.00 | 1,005.00 | 1,234.00 | 1,380.00 | 1,862.00 | 2,934.00 | 3,547.00 | 3,702.00 | 2,539.00 | 4,430.00 | 5,888.00 | 4,000.00 | 1,556.00 | 3,046.00 | 1,161.00 | |
| Profit Margin | 22.16 | 21.31 | 24.45 | 25.02 | 26.87 | 30.25 | 32.95 | 32.34 | 20.69 | 32.93 | 40.96 | 29.76 | 14.17 | 29.95 | 11.81 | |
| EBITDA | 1,771.00 | 1,945.00 | 1,984.00 | 2,023.00 | 2,807.00 | 4,350.00 | 5,521.00 | 6,541.00 | 6,526.00 | 6,860.00 | 7,518.00 | 4,807.00 | 3,656.00 | 2,686.00 | 2,598.00 | |
| EBITDA Margin | 40.48 | 41.25 | 39.31 | 36.68 | 40.50 | 44.84 | 51.30 | 57.14 | 53.17 | 50.99 | 52.29 | 35.76 | 33.30 | 26.40 | 26.42 | |
| Operating Income | 1,295.00 | 1,248.00 | 1,724.00 | 1,855.00 | 2,515.00 | 3,972.00 | 4,891.00 | 5,150.00 | 5,344.00 | 5,888.00 | 7,042.00 | 4,550.00 | 2,840.00 | 2,320.00 | 1,296.00 | |
| Operating Margin | 29.59 | 26.48 | 34.16 | 33.64 | 36.29 | 40.94 | 45.44 | 44.99 | 43.54 | 43.77 | 48.98 | 33.84 | 25.87 | 22.81 | 13.18 | |
| Interest Income | 48.00 | 22.00 | 19.00 | 29.00 | 8.00 | 12.00 | 22.00 | 63.00 | 78.00 | 112.00 | 120.00 | 42.00 | 11.00 | 89.00 | 276.00 | |
| Loss | -3,081.00 | -3,147.00 | -3,304.00 | -3,677.00 | -4,442.00 | -5,786.00 | -5,748.00 | -5,795.00 | -6,746.00 | -7,452.00 | -7,342.00 | -8,998.00 | -8,173.00 | -7,271.00 | -8,004.00 | |
| Cost of Revenue | -382.00 | -400.00 | -466.00 | -545.00 | -857.00 | -1,171.00 | -1,240.00 | -1,478.00 | -1,630.00 | -1,816.00 | -1,955.00 | -1,805.00 | -2,109.00 | -2,278.00 | -2,533.00 | |
|
Operating Expenses
|
-2,699.00 | -2,747.00 | -2,838.00 | -3,132.00 | -3,584.00 | -4,615.00 | -4,508.00 | -4,317.00 | -5,116.00 | -5,635.00 | -5,386.00 | -7,193.00 | -6,064.00 | -4,993.00 | -5,471.00 | |
| R&D | -1,283.00 | -1,248.00 | -1,219.00 | -1,334.00 | -1,444.00 | -1,893.00 | -2,012.00 | -1,973.00 | -2,253.00 | -2,597.00 | -2,280.00 | -3,990.00 | -2,501.00 | -2,231.00 | -2,462.00 | |
| G&A | - - | - - | - - | -1,223.00 | -1,639.00 | -2,139.00 | -2,004.00 | -1,841.00 | -1,860.00 | -2,016.00 | -2,295.00 | -2,392.00 | -2,575.00 | -2,349.00 | -2,478.00 | |
| SG&A | -1,126.00 | -1,289.00 | -1,373.00 | -1,277.00 | -1,712.00 | -2,232.00 | -2,113.00 | -1,947.00 | -1,935.00 | -2,106.00 | -2,374.00 | -2,504.00 | -2,674.00 | -2,403.00 | -2,549.00 | |
| S&M | - - | - - | - - | -54.00 | -72.00 | -92.00 | -108.00 | -106.00 | -75.00 | -90.00 | -79.00 | -111.00 | -98.00 | -54.00 | -71.00 | |
| Depreciation and Amortization | -427.00 | -354.00 | -358.00 | -365.00 | -531.00 | -688.00 | -600.00 | -682.00 | -1,081.00 | -1,016.00 | -680.00 | -457.00 | -487.00 | -518.00 | -494.00 | |
| Interest Expenses | -35.00 | -36.00 | -33.00 | -36.00 | -31.00 | -29.00 | -95.00 | -260.00 | -250.00 | -200.00 | -187.00 | -222.00 | -253.00 | -246.00 | -246.00 | |
| Other Expenses | -24.00 | -325.00 | -32.00 | -16.00 | -9.00 | -29.00 | -247.00 | -720.00 | -399.00 | -101.00 | -83.00 | -497.00 | -1,095.00 | -1,271.00 | -563.00 | |
|
WA Shares Outstanding
|
287.00 | 252.00 | 242.00 | 237.00 | 236.00 | 236.00 | 230.00 | 218.00 | 212.00 | 204.00 | 187.00 | 160.00 | 149.00 | 145.00 | 144.00 | |
| Diluted | 289.00 | 254.00 | 245.00 | 239.00 | 238.00 | 237.00 | 231.00 | 218.00 | 213.00 | 205.00 | 187.00 | 161.00 | 149.00 | 146.00 | 145.00 |